Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MIT's smart pillbox targets TB

04.03.2008
Tuberculosis has long been eradicated from the world's industrialized nations but continues to take a terrible toll in a few poor, rural regions of Asia and Africa. Every year, 10 million new cases are diagnosed and two million people die of the disease.

It's not that new treatments are needed--medical science long ago figured out how to cure tuberculosis using a cocktail of antibiotics.

The problem is getting the medicine to the people who need it and, most difficult, making sure they follow the six-month regimen of daily doses.

Failure to follow the regimen not only leads to likely death of that patient, but fosters the development of antibiotic-resistant strains of the disease. "The problem is, how do you get people to take this complex regimen," says Manish Bhardwaj, a doctoral student in the Department of Electrical Engineering and Computer Science who works in the Microsystems Technology Laboratories.

After a year of hard work and about eight revisions, Bhardwaj and a team of collaborators think they may have found the answer. It's a high-tech solution in a simple, inexpensive and easy-to-use -package.

The first part of the two-component system is a kind of "smart"
pillbox, called the uBox. It has 14 chambers that can each be loaded with several pills, which it dispenses from one chamber per day. To alert the patient that it's time to take the medicine, the box flashes its lights and sounds a buzzer. When the compartment is opened, the uBox records the exact time and prevents double-dosing by refusing to open again until the next treatment is due.

After two weeks, a health care worker reloads the box and digitally records and transmits the information stored in it. Doctors and public health services can then get complete data on compliance, patient by patient, in almost real time, instead of having to wait until the end of the six-month treatment.

"How do you know if pills are getting to the patients or if patients are taking them? Today, there's no good way of doing this," Bhardwaj says. If people fail to take all their pills, "it is possible to do harm by treatment that doesn't have good adherence." Missing medication can lead to the development of resistant strains, which can then be spread by that noncompliant patient. "The people they infect have no chance." Today, less than half of the patients that start the regimen successfully complete it.

"We want to make sure the worker is motivated," Bhardwaj says, and at present there's no way to tell which workers are diligent about making the calls and which ones may skip some of their appointed -visits. Accordingly, the uBox has an additional feature: a receptacle for a tiny key, like a headphone plug, which is carried by the visiting health care worker. At each visit the worker inserts the key, thus recording the fact that the patient really has been visited--another important gauge of compliance.

The second part of the group's new system is a cell phone, called the uPhone. By using special software, health care workers can record a patient's temperature, weight, and answers to a list of questions related to symptoms, which adds to the set of detailed patient data analyzed by doctors monitoring the study.

By looking at patterns of effects, the doctors can tell which field workers are achieving the best adherence rates with their patients and find out just what it is that those people are doing right. They can then be recruited to train additional workers.

Bhardwaj has been working with MIT alumni Goutam Reddy and Sara Cinnamon on the engineering and electronics of the pillbox, doctoral student Bill Thies and alumnus Pallavi Kaushik on the uPhone software, and MIT seniors Oliver Venn and Jessica Leon on fundraising and logistics.

Bhardwaj and Thiess went to Bihar province this January to begin their first field test of the product, conducting a training session for 22 workers who will, in turn, train the field workers to distribute the pillboxes in the field. In late April Bhardwaj will return to Bihar to train workers at two new sites. The first actual field test with 100 of the boxes and 10 cell phones should start in mid-May.

If all goes well, a second round of testing, using 1,000 uBoxes, is set to begin. After that, it all depends on the results--and on the ability to raise funds for future deployment. Health officials in India are already keenly interested in this test, and Bhardwaj is about to meet with representatives of the Bill & Melinda Gates Foundation to discuss possible collaboration and support.

The Ven. Tenzin Priyadarshi, MIT's Buddhist chaplain, helped to get the project started and says, "I am hopeful that the uBox-uPhone project will revolutionize the way we understand and provide health care in rural areas of the world."

While Bhardwaj is proud of the product his team developed, he is not proprietary about it. "We hope to make the uBox and the uPhone the standard of treatment in Bihar. We worked very hard to make something very simple and elegant," he says. "But we'd be delighted if someone beats us to it and builds a uBox cheaper. We hope other people will copy us."

Written by David Chandler, MIT News Office

Elizabeth A. Thomson | MIT News Office
Further information:
http://www.mit.edu

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

Researchers make flexible glass for tiny medical devices

24.03.2017 | Materials Sciences

Laser activated gold pyramids could deliver drugs, DNA into cells without harm

24.03.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>